Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

VTT introduces a new biotechnological method for anti-cancer drug production

19.05.2004


Less expensive production method reduces the costs on the consumer and society



VTT Technical Research Centre of Finland and the Belgian institute VIB (Flander Interuniversity Institute for Biotechnology) have developed a new, efficient method for producing plant-derived compounds in cell cultures. Such compounds are for example used for expensive special pharmaceuticals. The new method will provide a more inexpensive and efficient method for producing anti-cancer drugs in the near future.

Isolating pharmaceuticals from plants is difficult due to their extremely low concentrations. Since the raw material is scarce or its chemical production is too difficult or even impossible, the industry currently lacks sufficient methods for producing all of the desired plant-derived pharmaceutical molecules. Some substances can only be isolated from extremely rare plants. The biotechnical method developed by VTT and VIB offers a quick and efficient method for producing these high-value medical compounds in cultivated cells. In the future, the new production method may also offer alternatives to other highly expensive drugs.


Chief Research Scientist Kirsi-Marja Oksman-Caldentey from VTT Biotechnology is leading a project, which purpose is to investigate how these valuable compounds can be produced by modifying cell metabolism. Live plant cells produce complex chemical compounds. By steering the cell metabolism, or metabolic engineering, it is possible to affect the production of the desired high-value compounds. It is also possible to use the new technology to produce totally new compounds. This is the first systematical study whose purpose is to analyse the plant cell biosynthesis, or the entire chain of events leading to the creation of compounds.

Today, one-fourth of all pharmaceuticals are of plant origin, either used as a pure compound or chemically engineered to form appropriate derivatives. These include compounds such as morphine, codeine and several anti-cancer drugs. The plant Catharanthus roseus (Madagaskar Periwinkle) is the source of a compound that is used in the treatment of advanced breast cancer and leukaemia, for example.

The results of VTT’s project are very promising, and currently VTT and VIB are now focusing on how to commercialise the method.

Kirsi-Marja Oksman-Caldentey | alfa
Further information:
http://www.vtt.fi

More articles from Health and Medicine:

nachricht Indications of Psychosis Appear in Cortical Folding
26.04.2018 | Universität Basel

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

World's smallest optical implantable biodevice

26.04.2018 | Power and Electrical Engineering

Molecular evolution: How the building blocks of life may form in space

26.04.2018 | Life Sciences

First Li-Fi-product with technology from Fraunhofer HHI launched in Japan

26.04.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>